Literature DB >> 21183225

Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

Sjoerd B A H A Fluitman1, Cobi J Heijnen, Damiaan A J P Denys, Willem A Nolen, Ferdi J Balk, Herman G M Westenberg.   

Abstract

BACKGROUND: Major depressive disorder is associated with alterations in the neuroendocrine as well as immune system. Few studies examined the impact of electroconvulsive therapy (ECT) on these systems in patients with major depressive disorder (MDD).
METHODS: In this explorative study 12 patients suffering from medication-resistant MDD or MDD with psychotic features were studied during the first, the fifth and eleventh session of ECT. Blood samples were taken immediately prior to the electrostimulus and 5, 15 and 30 min after the electrostimulus to assess various lipopolysaccharide (LPS) stimulated or T-cell mitogen induced cytokines, immune cell numbers, Natural Killer cell activity, cortisol and ACTH.
RESULTS: Acute ECT increased the LPS-stimulated production of the cytokines IL-6 and TNF-α by peripheral monocytes but not the production of the anti-inflammatory cytokine IL-10. Acute ECT decreased T cell mitogen-induced levels of IFN-γ but IL-10 and IL-4 levels were left unaffected while NK cell activity increased momentarily but significantly. Cortisol and ACTH rose significantly after electrostimulus. Repeated ECT had no significant effect on any of the parameters. LIMITATIONS: The study had a small group size. Also the patient group was heterogeneous as it consisted of patients with therapy-resistant depression with or without psychotic features.
CONCLUSIONS: Results suggest that acute ECT is associated with transient immunological and neuro-endocrine changes, while repeated ECT does not have an additive effect on the immune and neuroendocrine functions.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183225     DOI: 10.1016/j.jad.2010.11.035

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

Review 1.  Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy.

Authors:  Jiangling Jiang; Jijun Wang; Chunbo Li
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

2.  Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Authors:  Gavin Rush; Aoife O'Donovan; Laura Nagle; Catherine Conway; AnnMaria McCrohan; Cliona O'Farrelly; James V Lucey; Kevin M Malone
Journal:  J Affect Disord       Date:  2016-06-17       Impact factor: 4.839

Review 3.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

4.  Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.

Authors:  Cinara Ludvig Gonçalves; Helena Mendes Abelaira; Thayse Rosa; Airam Barbosa de Moura; Deise Cristina Veron; Laura Araújo Borba; Maria Eduarda Mendes Botelho; Mariana Pereira Goldim; Leandro Garbossa; Maria Eduarda Fileti; Fabricia Petronilho; Zuleide Maria Ignácio; João Quevedo; Gislaine Zilli Réus
Journal:  Pharmacol Rep       Date:  2021-01-03       Impact factor: 3.024

Review 5.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

6.  Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat.

Authors:  Erlyn Limoa; Sadayuki Hashioka; Tsuyoshi Miyaoka; Keiko Tsuchie; Ryosuke Arauchi; Ilhamuddin A Azis; Rei Wake; Maiko Hayashida; Tomoko Araki; Motohide Furuya; Kristian Liaury; Andi J Tanra; Jun Horiguchi
Journal:  J Neuroinflammation       Date:  2016-09-02       Impact factor: 8.322

7.  Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.

Authors:  Jennifer L Kruse; Eliza Congdon; Richard Olmstead; Stephanie Njau; Elizabeth C Breen; Katherine L Narr; Randall Espinoza; Michael R Irwin
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 5.906

8.  Electroconvulsive seizures (ECS) do not prevent LPS-induced behavioral alterations and microglial activation.

Authors:  E M van Buel; F J Bosker; J van Drunen; J Strijker; W Douwenga; H C Klein; U L M Eisel
Journal:  J Neuroinflammation       Date:  2015-12-12       Impact factor: 8.322

9.  Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study.

Authors:  E Iacob; S C Tadler; K C Light; H R Weeks; K W Smith; A T White; R W Hughen; T A VanHaitsma; L A Bushnell; A R Light
Journal:  Depress Res Treat       Date:  2014-04-13

Review 10.  Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?

Authors:  E M van Buel; K Patas; M Peters; F J Bosker; U L M Eisel; H C Klein
Journal:  Transl Psychiatry       Date:  2015-07-28       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.